C07C 327/40
Having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to
Official title: having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
C07C327/40 (Having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to) appears on 159 US grants and 115 published applications in this corpus.
Search patents in C07C- Granted patents
- 159
- Published applications
- 115
- Assignees
- 110
- Inventors
- 444
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 9 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 10 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 11 | 2 |
| 2002 | 3 | 9 |
| 2003 | 8 | 8 |
| 2004 | 5 | 10 |
| 2005 | 3 | 4 |
| 2006 | 6 | 4 |
| 2007 | 3 | 3 |
| 2008 | 0 | 1 |
| 2009 | 3 | 5 |
| 2010 | 1 | 3 |
| 2011 | 5 | 6 |
| 2012 | 3 | 6 |
| 2013 | 3 | 7 |
| 2014 | 5 | 6 |
| 2015 | 4 | 8 |
| 2016 | 10 | 9 |
| 2017 | 8 | 6 |
| 2018 | 2 | 3 |
| 2019 | 4 | 1 |
| 2020 | 0 | 2 |
| 2021 | 2 | 1 |
| 2022 | 1 | 3 |
| 2023 | 1 | 1 |
| 2024 | 1 | 4 |
| 2025 | 1 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Compounds and methods for the treatment of parasitic infections26 Aug 2025US 12,396,969 B2The Board of Trustees of the University of Illinois
- Functionally modified polypeptides and radiobiosynthesis26 Mar 2024US 11,939,617 B2Ikaria, Inc.
- Broad spectrum antivirulence, anti-persistence compounds22 Aug 2023US 11,731,946 B2Aptuit (Verona) SRL, An Evotec Company
- Functionally modified polypeptides and radiobiosynthesis4 Jan 2022US 11,214,820 B2Ikaria, Inc.
- Benzylamide compound, method for producing the same, and miticide11 May 2021US 11,000,037 B2OAT Agrio Co., Ltd.
- Compounds and methods for the treatment of parasitic infections25 Dec 2025US 2025/0387359 A1The Board of Trustees of the University of Illinois
- Formation of amidines4 Dec 2025US 2025/0368679 A1
- Inhibitors of p1b-type atpases16 Jan 2025US 2025/0017889 A1The Curators of the University of Missouri
- Isolated trans isomer of 3-(2-bromo-3,4-dihydroxy-phenyl)-n-(3,4,5-trihydroxy-benzyl)-thioacrylamide26 Dec 2024US 2024/0425452 A1Tyrnovo Ltd.
- Phenoxy-acetyl-thioureido-benzenesulfonamide derivatives, and their uses28 Nov 2024US 2024/0391872 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Methods and compositions for inhibiting cell proliferative disorders109US 5,789,427 ASugen, Inc. · 1998
- FLK-1 is a receptor for vascular endothelial growth factor90US 5,851,999 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1998
- Methods and compositions for inhibiting cell proliferative disorders85US 5,773,476 ASugen, Inc. · 1998
- Quinazoline compounds and compositions thereof for the treatment of disease84US 5,792,771 ASugen, Inc. · 1998
- 2-oxindole compounds which are useful as tyrosine kinase inhibitors72US 5,374,652 AFarmitalia Carlo Erba S r l · 1994